Bingjie Zeng

1.1k total citations · 1 hit paper
21 papers, 892 citations indexed

About

Bingjie Zeng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bingjie Zeng has authored 21 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Bingjie Zeng's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and Extracellular vesicles in disease (3 papers). Bingjie Zeng is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and Extracellular vesicles in disease (3 papers). Bingjie Zeng collaborates with scholars based in China, Germany and United States. Bingjie Zeng's co-authors include Junlu Wu, Anquan Shang, Zujun Sun, Chenzheng Gu, Weiwei Wang, Ping Ji, Junjun Sun, Dong Li, Chen Chen and Yibao Yang and has published in prestigious journals such as Oncogene, The FASEB Journal and Molecular Cancer.

In The Last Decade

Bingjie Zeng

19 papers receiving 885 citations

Hit Papers

Exosomal circPACRGL promotes progression of colorectal ca... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingjie Zeng China 9 667 527 165 132 60 21 892
Anastasia A. Ponomaryova Russia 12 493 0.7× 370 0.7× 209 1.3× 185 1.4× 145 2.4× 25 785
Uksha Saini United States 14 363 0.5× 209 0.4× 89 0.5× 123 0.9× 26 0.4× 26 584
Jingxin Ding China 16 686 1.0× 597 1.1× 65 0.4× 81 0.6× 25 0.4× 41 925
Kegan Zhu China 14 1.3k 2.0× 1.2k 2.2× 95 0.6× 102 0.8× 119 2.0× 19 1.6k
Luojing Chen United States 14 357 0.5× 153 0.3× 121 0.7× 107 0.8× 37 0.6× 26 549
Wolfgang Goering Germany 18 593 0.9× 273 0.5× 61 0.4× 191 1.4× 159 2.6× 26 835
Yisheng Fang United States 16 296 0.4× 207 0.4× 67 0.4× 171 1.3× 87 1.4× 45 737
Chi Lam Au Yeung United States 7 913 1.4× 758 1.4× 135 0.8× 214 1.6× 55 0.9× 15 1.2k
Guanyi Kong China 8 480 0.7× 348 0.7× 39 0.2× 150 1.1× 69 1.1× 9 754
Eva De Smedt Belgium 11 540 0.8× 216 0.4× 61 0.4× 161 1.2× 44 0.7× 19 681

Countries citing papers authored by Bingjie Zeng

Since Specialization
Citations

This map shows the geographic impact of Bingjie Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingjie Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingjie Zeng more than expected).

Fields of papers citing papers by Bingjie Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingjie Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingjie Zeng. The network helps show where Bingjie Zeng may publish in the future.

Co-authorship network of co-authors of Bingjie Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Bingjie Zeng. A scholar is included among the top collaborators of Bingjie Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingjie Zeng. Bingjie Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yiran, Dan Li, Yuan Deng, et al.. (2025). NSUN2/ALYREF axis-driven m5C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer. Cancer Immunology Immunotherapy. 74(4). 132–132. 6 indexed citations
2.
Sheng, Anzhi, Bingjie Zeng, Haizhen Jin, et al.. (2025). Dynamic DNA assembly-assisted CRISPR/Cas12a system for lung cancer-associated miRNA analysis. Materials Today Bio. 32. 101671–101671. 2 indexed citations
3.
Li, Lan, Haixia Jiang, Bingjie Zeng, et al.. (2024). Liquid biopsy in lung cancer. Clinica Chimica Acta. 554. 117757–117757. 13 indexed citations
4.
Zeng, Bingjie, et al.. (2024). MFAP2 upregulation promotes ESCC metastasis via FAKAKT signaling pathway. The FASEB Journal. 38(24). e70266–e70266. 1 indexed citations
5.
Xu, Xin, Shiyu Qiu, Bingjie Zeng, et al.. (2024). N6-methyladenosine demethyltransferase FTO mediated m6A modification of estrogen receptor alpha in non-small cell lung cancer tumorigenesis. Oncogene. 43(17). 1288–1302. 5 indexed citations
6.
Wang, Xianzhao, et al.. (2024). Research Progress of Liquid Biopsy Based on DNA Methylation in Tumor Diagnosis and Treatment. Biomolecules. 14(12). 1634–1634.
7.
Zeng, Bingjie, Xianzhao Wang, Congcong Zhang, et al.. (2023). Differences in serum cytokine levels distinguish between clinically non‐invasive lung adenocarcinoma and invasive lung adenocarcinoma: A cross‐sectional study. Health Science Reports. 6(9). e1522–e1522. 5 indexed citations
9.
Sun, Junjun, et al.. (2021). N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 705962–705962. 11 indexed citations
10.
Zhong, Ming, Bingjie Zeng, Dongying Tang, et al.. (2021). The blue light receptor CRY1 interacts with GID1 and DELLA proteins to repress GA signaling during photomorphogenesis in Arabidopsis. Molecular Plant. 14(8). 1328–1342. 60 indexed citations
11.
Zeng, Bingjie, Ping Ji, Chen Chen, et al.. (2020). A nomogram from the SEER database for predicting the prognosis of patients with non-small cell lung cancer. The International Journal of Biochemistry & Cell Biology. 127. 105825–105825. 5 indexed citations
12.
Shang, Anquan, Chenzheng Gu, Chen Zhou, et al.. (2020). Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression. Cell Communication and Signaling. 18(1). 52–52. 100 indexed citations
13.
Shang, Anquan, Chenzheng Gu, Weiwei Wang, et al.. (2020). Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis. Molecular Cancer. 19(1). 117–117. 342 indexed citations breakdown →
14.
Shang, Anquan, Xuan Wang, Chenzheng Gu, et al.. (2020). Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1. Aging. 12(9). 8352–8371. 73 indexed citations
15.
Shang, Anquan, Weiwei Wang, Chenzheng Gu, et al.. (2020). Correction to: Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils. Journal of Experimental & Clinical Cancer Research. 39(1). 3 indexed citations
16.
Shang, Anquan, Chenzheng Gu, Xuan Wang, et al.. (2020). Exosomal miR-183-5p Promotes Angiogenesis of Colorectal Cancer by Regulation of FOXO1. SSRN Electronic Journal. 2 indexed citations
17.
Ji, Ping, Yibao Yang, Junlu Wu, et al.. (2019). Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling. Theranostics. 9(8). 2209–2223. 39 indexed citations
18.
Shang, Anquan, Weiwei Wang, Chenzheng Gu, et al.. (2019). Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils. Journal of Experimental & Clinical Cancer Research. 38(1). 272–272. 160 indexed citations
19.
Shang, Anquan, Chenzheng Gu, Wenfang Liu, et al.. (2019). Exosomal KRAS Mutation Promotes Promotion of Colorectal Cancer by the Formation of Tumor-Associated Neutrophil Extracellular Traps. SSRN Electronic Journal. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026